Managed Healthcare Executive
banner
mhexecutive.bsky.social
Managed Healthcare Executive
@mhexecutive.bsky.social
Helping managed care executives succeed every day.
Growing burden of generalized anxiety disorder showecased in one of the most detailed estimates to date #anxiety #GAD
www.managedhealthcareexecutive.com/view/general...
October 28, 2025 at 8:59 PM
The COVID vaccine is still effective, associated with lower risks of COVID-related outcomes over six months, study shows
www.managedhealthcareexecutive.com/view/2024-20...
2024–2025 COVID Vaccine Linked to Lower Risks of Hospitalization and Death Among U.S. Veterans
A study revealed that the 2024-2025 COVID-19 vaccine significantly reduces emergency visits, hospitalizations and deaths among U.S. veterans.
www.managedhealthcareexecutive.com
October 14, 2025 at 4:02 PM
Pfizer is the first pharmaceutical company to participate in President Donald Trump’s Most Favored Nation pricing
www.managedhealthcareexecutive.com/view/introdu...
Introducing TrumpRx, the White House’s Direct-to-Consumer Platform for Prescription Drugs
As part of the Most Favored Nation pricing effort, Pfizer has agreed to invest in U.S. manufacturing and to allow access to its drugs at a discount through a new direct-to-patient website.
www.managedhealthcareexecutive.com
September 30, 2025 at 5:45 PM
Reposted by Managed Healthcare Executive
🗣️📚In an interview with @mhexecutive.bsky.social, #CUNYSPH alum Alexa D’Angelo, PhD, MPH, discusses her study on insurance denials & cost sharing for PrEP among sexual & gender minority people.
🔗 cunysph.me/4lUOnXX
A Conversation With Alexa D’Angelo, Ph.D., M.P.H., Recent Doctoral Graduate from the CUNY School of Public Health and Health Policy
Sexual and gender minority individuals still face insurance denials and cost-sharing barriers when accessing pre-exposure prophylaxis (PrEP), despite having a Grade A recommendation from the United…
cunysph.me
September 4, 2025 at 2:47 PM
A half-dozen takeaways from an MJH Life Sciences webinar on the Trump administration's push for most-favored nation drug pricing
www.managedhealthcareexecutive.com/view/6-thing...
6 Things You Need to Know About MFN Drug Pricing | MJH Life Sciences Webinar
A half-dozen takeaways from an MJH Life Sciences webinar on the Trump administration's push for most-favored nation drug pricing
www.managedhealthcareexecutive.com
September 16, 2025 at 3:41 PM
A Trilliant Health analysis finds that procedure prices can vary by tens of thousands of dollars based on health plan. #MedicalCosts #HealthPlans
www.managedhealthcareexecutive.com/view/health-...
Health Plans Negotiate Different Prices for the Same Procedures
In an analysis from Trilliant Health of 11 inpatient and outpatient procedures, Aetna and UnitedHealthcare had huge variations in rates across the country, across states, and even at the same facility...
www.managedhealthcareexecutive.com
August 19, 2025 at 4:05 PM
A single gene therapy injection at birth protected infant macaques from HIV for at least 3 years in a preclinical trial—offering hope for long-term prevention in humans. www.managedhealthcareexecutive.com/view/a-conve...
A Conversation With Amir Ardeshir, Ph.D., DVM, Associate Professor of Microbiology and Immunology at Tulane University
HIV-fighting antibodies produced in infant macaques in a preclinical trial could be the future of HIV prevention in humans, according to Amir Ardeshir, Ph.D., DVM, Associate Professor of Microbiology ...
www.managedhealthcareexecutive.com
August 12, 2025 at 3:46 PM
The (M) Factor Global Impact Report 2025 highlights worldwide gaps in menopause knowledge and care, with impacts on health, work and daily life. #Menopause #WomensHealth
www.managedhealthcareexecutive.com/view/gaps-in...
Gaps in Menopause Knowledge, Care Showcased in The (M) Factor Global Impact Report
International audience surveys from last year’s menopause documentary, The (M) Factor, shed light on the ongoing need for increased menopause awareness for patients and providers alike.
www.managedhealthcareexecutive.com
August 5, 2025 at 3:30 PM
UnitedHealth Group announced this morning that it had updated its 2025 outlook to adjusted earnings of $16 per share
www.managedhealthcareexecutive.com/view/unitedh...
#UnitedHealth
UnitedHealth Group Resets Earnings Projections Way Below Previous Expectations
The healthcare conglomerate says rising medical costs are squeezing earnings from operations.
www.managedhealthcareexecutive.com
July 29, 2025 at 3:20 PM
Sarepta Therapeutics will temporarily stop shipping Elevidys in the United States at the end of business today, July 22, 2025.
www.managedhealthcareexecutive.com/view/sarepta...
Sarepta to Pause Shipments of the Gene Therapy Elevidys
Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators while they address a safety labeling update about the risk of acute liver ...
www.managedhealthcareexecutive.com
July 22, 2025 at 3:28 PM
The International AIDS Society (IAS) held a press conference today at the IAS 2025 meeting in Kigali, Rwanda, about the future of HIV science. From left: Beatriz Grinstejn, Kenneth Ngure, Linda-Gail Bekker and Sharon Lewin. #IAS2025
July 15, 2025 at 3:18 PM
A large UK study of 1.5 million people has found that autoimmune diseases nearly double your risk of developing mental health conditions—including depression, anxiety and bipolar disorder.
www.managedhealthcareexecutive.com/view/autoimm...
Autoimmune Diseases Almost Double Mental Health Disorder Risk
The prevalence of autoimmune disease patients with a mental health disorder is almost twice the number of patients without, suggesting there is a link between inflammation and conditions such as depre...
www.managedhealthcareexecutive.com
July 8, 2025 at 4:34 PM
Big FDA decisions coming in late 2025!
New treatments for heart disease and rare blood disorders & more could be approved soon.
Keep an eye on rilzabrutinib, aficamten and others.

Full list: www.managedhealthcareexecutive.com/view/expecte...
Expected FDA Approvals in the Second Half of 2025
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
www.managedhealthcareexecutive.com
July 1, 2025 at 5:24 PM
Novo Nordisk ends partnership with Hims & Hers, citing safety concerns over compounded semaglutide. Hims pushes back, claiming pressure to steer patients to branded Wegovy. Hims & Hers stock has dropped more than 30%
www.managedhealthcareexecutive.com/view/novo-no...

#Wegovy #GLP1
Novo Nordisk Terminates Collaboration with Hims & Hers
The FDA had resolved the shortage of Wegovy in April, and telehealth providers were advised to stop selling compounded semaglutide products. Novo Nordisk said that Hims & Hers continues to offer these...
www.managedhealthcareexecutive.com
June 24, 2025 at 4:11 PM
Only 27% of Gen Z willing to pay more than $100 out of pocket per month for GLP-1s, compared to 6% of Baby Boomers
www.managedhealthcareexecutive.com/view/83-of-a...
83% of Americans Unwilling to Pay More Than $100 for GLP-1s, Survey Shows
Gen Z was the age group most likely to spend the money on GLP-1 agonists; still, only 27% would.
www.managedhealthcareexecutive.com
June 10, 2025 at 3:44 PM
The number of hospitalized chronic liver disease patients with acute kidney injury increased by nearly 35% from 2018 to 2023, with inpatient costs rising more than 17% to $165,458
www.managedhealthcareexecutive.com/view/proport...
Proportion and Costs of Hospitalizations for Cirrhosis With AKI and HRS Are Rising Fast, Study Finds
Researchers found that nearly 28% of hospitalized chronic liver disease patients with acute kidney injury had alcohol-related disorders, as did almost 60% with hepatorenal syndrome.
www.managedhealthcareexecutive.com
May 27, 2025 at 4:51 PM
COVID-19 may have lasting effects on kidney health, potentially leading to chronic kidney disease post-recovery. How might this change our post-COVID healthcare approach? Share your thoughts! #COVID19 www.managedhealthcareexecutive.com/view/covid-1...
COVID-19 Linked to Development of Chronic Kidney Disease Months After Illness
Men and people ages 45 and older face additional risk of serious kidney conditions six to 12 months after their viral illness, a study finds.
hubs.li
May 20, 2025 at 5:05 PM
Health policy leaders and patient advocates are raising red flags about the new Republican proposal they say would “slash” Medicaid coverage
www.managedhealthcareexecutive.com/view/healthc...
Healthcare Leaders Warn GOP Plan Would Deeply Chip Away At Medicaid Access
Their concerns come in response to the bill unveiled Sunday night by House Republicans that would tighten eligibility rules, create work requirements and freeze provider taxes under Medicaid—the feder...
www.managedhealthcareexecutive.com
May 13, 2025 at 3:41 PM
Many questions remain regarding the Trump administration’s position on the future of Medicare and MA.
www.managedhealthcareexecutive.com/view/will-th...
Will the Trump Administration Advantage Medicare Advantage?
Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.
www.managedhealthcareexecutive.com
May 6, 2025 at 6:32 PM
Healthcare has largely been in the backseat during the first 100 days of the second Trump administration in contrast to the first one, Assembia panelists say
www.managedhealthcareexecutive.com/view/how-hea...
How Healthcare Fared in the First 100 Days of the Second Trump Administration | Asembia's AXS25 Summit
Healthcare hasn't been a priority of the second Trump administration so far, panelists at the Asembia agreed. Medicaid may loom large, though, as the administration and congressional Republicans look ...
www.managedhealthcareexecutive.com
April 29, 2025 at 6:19 PM